Business Context and Reporting Period
This Form 8-K is a Current Report filed by East Resources Acquisition Company (ERES), a Delaware corporation and emerging growth company, on December 2, 2022. The filing reports the termination of a material definitive agreement. ERES is a special purpose acquisition company (SPAC) with securities trading on the NASDAQ Stock Market under the symbols ERESU, ERES, and ERESW.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or liquidity metrics. The report focuses exclusively on the legal termination of a Forward Purchase Agreement. No debt or margin data is provided in this document.
Material Changes
- Termination of Forward Purchase Agreement: On December 2, 2022, ERES and East Asset Management, LLC (the "Purchaser") entered into a Termination Agreement to cancel the Forward Purchase Agreement originally dated July 2, 2020.
- Release of Liabilities: The parties agreed that no payments or deliveries are due regarding the terminated agreement and mutually released each other from all liabilities arising from it.
- Context of Merger: This termination occurred while ERES was in the process of a proposed merger with Longevity Market Assets, LLC and Abacus Settlements, LLC (the "Companies"), pursuant to a Merger Agreement signed on August 30, 2022, and amended on October 14, 2022.
Guidance, Outlook, and Risks
The filing contains extensive forward-looking statements regarding the proposed merger with the Companies, including anticipated benefits, timing, and pro forma enterprise value. Management cautions that actual results may differ materially due to various risks, including:
- Failure to complete the proposed transactions by the business combination deadline.
- Inability to satisfy conditions for consummation, such as stockholder approvals or regulatory clearances.
- Disruption to the Companies' operations and employee retention.
- Industry-specific risks in the life settlement sector, such as changes in longevity assumptions or premium costs.
- Legal challenges regarding the validity of life settlements.
Investors are directed to the preliminary proxy statement on Schedule 14A for detailed risk factors and additional information regarding the proposed transactions.
Important Facts for Investor Verification
- Verify the status of the proposed merger with Longevity Market Assets, LLC and Abacus Settlements, LLC, as the termination of the Forward Purchase Agreement may impact capital structure or funding.
- Review the preliminary proxy statement on Schedule 14A for details on the merger consideration (approximately 53.1 million newly issued shares at $10.00 per share) and redemption rights.
- Confirm the business combination deadline for ERES and whether an extension has been sought or granted.
- Assess the impact of the terminated Forward Purchase Agreement on the company's liquidity and ability to fund the proposed merger.